Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      GSK and CureVac announce strategic mRNA technology collaboration

      Drug Development
      GlaxoSmithKline plc and CureVac announced the signing of a strategic collaboration agreement for the research, development, manufacturing and commercialisation of up to five mRNA-based...

      GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine

      Drug Development
      GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic...

      Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development

      Drug Development
      Sanofi and The University of Texas MD Anderson Cancer Center announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted...

      TREMFYA Approved by U.S. FDA as the First Selective Interleukin Inhibitor for Active Psoriatic Arthritis

      FDA Approvals
      The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. FDA has approved TREMFYA for adult patients with active psoriatic arthritis (PsA),...

      Humanigen Expands Partnership with Catalent Biologics to Manufacture Investigational COVID-19 Therapeutic Candidate Lenzilumab

      Drug Development
      Catalent and Humanigen, Inc. announced the expansion of their relationship, under which Catalent will provide development, manufacturing and commercialization services for lenzilumab, Humanigen’s proprietary...

      Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia

      Drug Development
      Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice,...

      Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19

      Drug Development
      In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the launch of antiviral drug Favipiravir...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.